• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Pfizer

Pfizer

Pfizer Inc PFE 3 Star

Last Price$28.96Day Change (%)-0.99%
Open Price$29.21Day Change ($)-0.29
Day Range28.83–29.3752-Week Range21.40–31.15

As of Fri 05/17/2013 07:09 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Pfizer PFE Q1 2013 Earnings Call Transcript

    Good day, everyone and welcome to Pfizer's First Quarter 2013 Earnings Conference Call. Today's call is being recorded.

  2. Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation

    Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation

  3. Pain Therapeutics: Pfizer Reassessing Continued Remoxy Partnership

    Pain Therapeutics: Pfizer Reassessing Continued Remoxy Partnership

  4. UPDATE: Drug Firms Stalk Actavis Deal

    UPDATE: Drug Firms Stalk Actavis Deal

  5. UPDATE: Drug Firms Stalk Actavis Deal

    UPDATE: Drug Firms Stalk Actavis Deal

  6. Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years

    Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years

  7. Pfizer 1st-Quarter Profit Up 53% on One-Time Gains; Cuts 2013 Outlook

    Pfizer 1st-Quarter Profit Up 53% on One-Time Gains; Cuts 2013 Outlook

  8. Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Celebration

    Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Celebration

  9. Novartis Considers Possible Bid for Actavis

    Novartis Considers Possible Bid for Actavis

  10. PULSE: Pfizer arthritis drug doesn't get European nod

    PULSE: Pfizer arthritis drug doesn't get European nod

12345
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.